The Optimist Daily · 7 days ago
For generations, sleeping sickness patients faced a cruel paradox: the treatment could be as deadly as the disease, with one widely used drug killing roughly one in 20 people who received it. Now, a three-pill, single-dose treatment called acoziborole has been cleared for use, replacing intravenous regimens and 10-day protocols that brought vomiting, heart disturbances, and burning veins -- side effects so severe that people chose to stay home and die rather than seek care. The drug works on both stages of the illness, and as Dr. Wilfried Mutombo Kalonji, who led clinical trials in remote areas of the Democratic Republic of Congo, puts it: "We can't dream to have better than this." With cases already down from hundreds of thousands to roughly 1,000 per year, health officials believe this tool could eliminate sleeping sickness by 2030 -- if the funding holds and the drug reaches the communities where fear of treatment once kept the sick in hiding.